Delta-8 and -9-THCO Classified as Schedule I Drugs

There’s more rough news for the U.S. hemp industry this week. The Drug Enforcement Agency (DEA) issued a letter stating that “delta” cannabinoids, including Delta-8 and Delta-9-THCO, synthetically derived from hemp do not qualify as hemp and will be viewed as Schedule I drugs. This is not a surprising stance from the DEA, considering our understanding of the delta derivatives and the law enforcement agency’s mandate.  

For those unfamiliar, the delta market includes a group of new cannabinoids synthesized chemically from legal hemp. Delta-9-THCO and Delta-8-THCO are the most common delta compounds in the market, and both produce an intoxicating high similar to that of Delta-9 THC – a compound specifically called out in the Controlled Substances Act (opens in new tab) as a Schedule I drug.

Read more here: Source link

Leave a Reply

Your email address will not be published. Required fields are marked *